Vaxzevria/COVID-19 Vaccine AstraZeneca: Risk of thrombosis in combination with thrombocytopenia - Updated information
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
|Therapeutic area (MeSH)||
COVID-19 virus infection
Type II variation
|Human ATC code||